Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $192.24 USD
Change Today +1.86 / 0.98%
Volume 392.2K
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joan E. Colligan

Former Controller and Executive Director, Jazz Pharmaceuticals Public Limited Company
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

64--

Background*

Ms. Joan E. Colligan served as Controller of Jazz Pharmaceuticals, Inc. since July 2004. Ms. Colligan served as Principal Accounting Officer of Jazz Pharmaceuticals, Inc. until March 9, 2011. Ms. Colligan served as an Acting Principal Financial Officer and Principal Accounting Officer of Jazz Pharmaceuticals, Inc. since March 2009. From 2000 to 2004, Ms. Colligan served as the Controller for research and development at ALZA Corporation. She received a B.S.C. and an M.B.A. ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 634 7800
Fax: 353 1 634 7850

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Santa Clara University
MBA
Santa Clara University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JAZZ:US $192.24 USD +1.86

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Jean-Jacques Bienaime MBAChairman and Chief Executive Officer
BioMarin Pharmaceutical Inc.
$916.0K
Rajat Rai Chief Executive Officer
Akorn, Inc.
$1.1M
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JAZZ PHARMACEUTICALS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.